Evaluation of phase I/II clinical trials
✍
Tjoa, B.A.; Simmons, S.J.; Bowes, V.A.; Ragde, H.; Rogers, M.; Elgamal, A.; Kenn
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 196 KB
👁 2 views
## Background: A phase i trial involving patients with advanced prostate cancer was conducted to assess the safe administration of dendritic cells (dc) and hla-a0201-specific prostate-specific membrane antigen (psma) peptides (psm-p1 or -p2). thirty-three of the phase i participants were subsequent